Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases

Respir Med Res. 2024 Jun:85:101070. doi: 10.1016/j.resmer.2023.101070. Epub 2023 Nov 30.
No abstract available

Keywords: Benralizumab; Dupilumab; EGPA; Eosinophilic granulomatosis with polyangiitis; Mepolizumab; Severe asthma.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Asthmatic Agents / administration & dosage
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma* / drug therapy
  • Asthma* / therapy
  • Churg-Strauss Syndrome / complications
  • Churg-Strauss Syndrome / diagnosis
  • Female
  • Granulomatosis with Polyangiitis* / complications
  • Granulomatosis with Polyangiitis* / diagnosis
  • Granulomatosis with Polyangiitis* / drug therapy
  • Granulomatosis with Polyangiitis* / therapy
  • Humans
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Th2 Cells / immunology

Substances

  • Anti-Asthmatic Agents